MGPI
Get informed when a big investor buys or sells
+ FollowUndervalued by 214% based on the discounted cash flow analysis.
| Market cap | $377.20 Million |
|---|---|
| Enterprise Value | $620.94 Million |
| Dividend Yield | $0.48 (2.72%) |
| Earnings per Share | $-4.99 |
| Beta | 0.49 |
| Outstanding Shares | 21,389,441 |
| P/E Ratio | -1.58 |
|---|---|
| PEG | -0.04 |
| Price to Sales | 0.68 |
| Price to Book Ratio | 0.6 |
| Enterprise Value to Revenue | 1.19 |
| Enterprise Value to EBIT | -2.33 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.44 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 15,800▲ 69.89% |
Holdings and activity of institutional investors.
| Ownership % | 72.26%▲ 0.72% |
|---|---|
| Total Invested | $284.17M▼ 23.52% |
| Investors Holding | 144▼ 36.00% |
No data
Provides critical analysis and scoring for all tax legislation, directly influencing corporate tax structures, deductions, and overall tax burden for manufacturing companies like MGPI.
Directly impacts corporate taxation, trade policy (tariffs on imported goods or exports), and other fiscal policies that significantly affect the profitability and operational costs of any manufacturing company.
Directly regulates agricultural policy (Farm Bill), commodity markets (CFTC), and crop support programs, which profoundly impact the cost and supply of raw materials (grains) for flour milling companies.
Directly regulates labor laws (minimum wage, union regulations) which are critical for manufacturing companies, and could influence food safety aspects if the FDA's role expands to specific ingredients or processes.